Business & Finance
Accuray posts Q3 fiscal net loss of USD8.9m
1 May 2018 -

Oncology company Accuray Incorporated (NASDAQ:ARAY) disclosed on Monday that it recorded a net loss of USD8.9m (USD0.10 per share) for the third fiscal quarter ended 31 March 2018.

This marks a decline in earnings when compared with a net loss of USD5.0m (USD0.06 per share) for the 2017 fiscal third quarter.

Total revenues of USD99.8m were collected for the third fiscal quarter ended 31 March 2018, up over USD97.3m in the prior fiscal year third quarter. Service revenue of USD56.6m for Q3 2018 fiscal, a rise from USD49.3m in the prior Q3 fiscal year. The increase in service revenue was driven by upgrade related sales.

Adjusted EBITDA of USD1.4m was announced for the 2018 fiscal third quarter, down over Adjusted EBITDA of USD7.1m in the prior fiscal year third quarter.

Login
Username:

Password: